TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, is excited to announce the launch of…
SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced the appointment of Tyler Binney to its Board of Directors. With a career built around scaling disruptive MedTech platforms, Binney brings over two decades…
Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, announces that Blue Cross and Blue Shield of Louisiana (BCBSLA) has added Kerecis MariGen® to its list of covered treatments for diabetic foot…
-Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of…
The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading global medical device and diagnostic company, to its Governance Committee. This appointment reflects Hologic’s commitment to…
NUBURU, Inc. (NYSE American: BURU), a leader in high-power blue laser technology under a pivotal transformation plan, entered into a standby equity purchase agreement (the “Agreement”) with YA II PN, Ltd. (the “Investor”) under which the company has the option,…
Actym Therapeutics, a clinical-stage therapeutic product development and platform company, announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and Trademark Office. These patents pertain to Actym’s novel therapeutic modality, which utilizes engineered bacteria…
Hyperfine’s Next-Gen Swoop® with Optive AI™ Gets FDA Clearance Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced today FDA clearance of…
–Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast board includes one investor director each from Arch Ventures, Illumina…
–Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from…